Skip to content

Combination Therapy with PRP and Transdermal Minoxidil for Androgenetic Alopecia: A Clinical Study on the Efficacy of Nanocrystalline Microneedle Delivery.

Combination Therapy with PRP and Transdermal Minoxidil for Androgenetic Alopecia: A Clinical Study on the Efficacy of Nanocrystalline Microneedle Delivery.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127344
Enrollment
Unknown
Registered
2026-06-30
Start date
2025-06-06
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia

Interventions

Group observing the combined use of platelet-rich plasma and minoxidil micro-penetration:None
The observation group was treated solely with platelet-rich plasma.:None

Sponsors

The Sixth Affiliated Hospital of GuangzhouMedical University,Qingyuan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) diagnosis of androgenetic alopecia according to the Chinese Clinical Dermatology (2nd edition) criteria; (2) no treatment for AGA (including pharmacologic or physical therapy) within the past month; and (3) age between 18 and 60 years with willingness to provide written informed consent.

Exclusion criteria

Exclusion criteria: (1) pregnancy, lactation, or planned pregnancy; presence of systemic diseases (e.g., diabetes, autoimmune disorders), psychiatric conditions (e.g., depression, anxiety), or active scalp infections (e.g., fungal infection); (2) current use of antiplatelet agents (e.g., aspirin, clopidogrel) or anticoagulant therapy (e.g., warfarin, low-molecular-weight heparin); and (3) AGA with onset or progression clearly influenced by psychiatric factors.

Design outcomes

Primary

MeasureTime frame
Hair count;Follicular status ;

Secondary

MeasureTime frame
Hair shaft diameter;Vellus hair count;

Countries

China

Contacts

Public Contactqiankun

Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital)

577966294@qq.com+86 763 311 3770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026